Tempest Therapeutics (TPST) Stock Chart & Stock Price History → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free TPST Stock Alerts $3.50 -0.12 (-3.31%) (As of 09:56 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tempest Therapeutics Stock Price Performance5 Day Performance-1.90%1 Month Performance-9.27%3 Month Performance-12.88%6 Month Performance+28.37%Year-To-Date Performance-17.73%1 Year Performance+76.59% Receive TPST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video TPST Stock Chart for Wednesday, May, 8, 2024 TPST Chart by TradingView Tempest Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$3.73$3.62-2.95%$3.76$3.60234,092 shs$80.44 million05/06/2024$3.69$3.73+1.08%$3.79$3.60213,251 shs$82.88 million05/03/2024$3.54$3.69+4.24%$3.77$3.56410,193 shs$81.99 million05/02/2024$3.62$3.54-2.21%$3.74$3.48482,658 shs$78.66 million05/01/2024$3.47$3.62+4.32%$3.67$3.42257,746 shs$80.44 million04/30/2024$3.44$3.47+0.87%$3.54$3.40244,063 shs$77.10 million Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$3.54$3.44-2.82%$3.72$3.44306,202 shs$76.43 million04/26/2024$3.48$3.54+1.72%$3.63$3.38402,438 shs$78.66 million04/25/2024$3.44$3.48+1.16%$3.49$3.31288,771 shs$77.22 million04/24/2024$3.42$3.44+0.58%$3.57$3.36652,486 shs$76.33 million04/23/2024$3.24$3.42+5.56%$3.47$3.24399,035 shs$75.89 million04/22/2024$3.10$3.24+4.52%$3.28$3.08390,804 shs$71.90 million04/19/2024$3.17$3.10-2.21%$3.26$3.06383,907 shs$68.79 million04/18/2024$3.27$3.17-3.06%$3.34$3.17315,091 shs$70.34 million04/17/2024$3.35$3.27-2.39%$3.34$3.22680,936 shs$72.56 million04/16/2024$3.34$3.35+0.30%$3.44$3.20470,813 shs$74.34 million04/15/2024$3.59$3.34-6.96%$3.63$3.31590,324 shs$74.12 million04/12/2024$3.85$3.59-6.75%$3.86$3.58462,763 shs$79.66 million04/11/2024$3.72$3.85+3.49%$3.95$3.72395,208 shs$85.44 million04/10/2024$3.87$3.72-3.88%$3.90$3.70460,222 shs$82.55 million04/09/2024$3.99$3.87-3.01%$4.18$3.79759,182 shs$85.88 million04/08/2024$3.72$3.99+7.26%$4.18$3.76780,945 shs$88.54 million04/05/2024$4.50$3.72-17.33%$4.46$3.572.52 million shs$82.55 million04/04/2024$5.13$4.50-12.20%$5.31$4.501.69 million shs$99.86 million04/03/2024$5.09$5.13+0.69%$5.33$4.751.07 million shs$113.72 million04/02/2024$5.44$5.09-6.43%$6.00$4.694.72 million shs$112.95 million04/01/2024$3.91$5.44+39.13%$5.90$3.8916.45 million shs$120.72 million03/29/2024$3.91$3.91$3.99$3.69677,974 shs$86.76 million03/28/2024$3.71$3.91+5.39%$3.99$3.69675,461 shs$86.76 million03/27/2024$3.71$3.71$3.94$3.66569,261 shs$82.33 million03/26/2024$3.64$3.71+1.92%$3.74$3.55343,108 shs$82.33 million03/25/2024$3.64$3.64$3.85$3.62438,490 shs$80.77 million03/22/2024$3.51$3.64+3.70%$3.65$3.45549,759 shs$80.77 million03/21/2024$3.76$3.51-6.65%$3.76$3.49573,557 shs$67.56 million03/20/2024$3.74$3.76+0.53%$3.79$3.48822,161 shs$72.38 million03/19/2024$3.87$3.74-3.36%$3.99$3.61751,308 shs$72.00 million03/18/2024$3.64$3.87+6.32%$4.08$3.64987,590 shs$74.50 million03/15/2024$3.43$3.64+6.12%$3.74$3.38684,348 shs$70.07 million03/14/2024$3.39$3.43+1.18%$3.79$3.37933,058 shs$66.03 million03/13/2024$3.38$3.39+0.30%$3.57$3.37385,572 shs$65.26 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$3.38$3.38$3.45$3.26479,641 shs$65.07 million03/11/2024$3.39$3.38-0.29%$3.52$3.36311,365 shs$65.07 million03/08/2024$3.50$3.39-3.14%$3.68$3.35455,636 shs$65.26 million03/07/2024$3.68$3.50-4.89%$3.70$3.41488,163 shs$67.36 million03/06/2024$3.17$3.68+16.09%$3.70$3.301.28 million shs$70.84 million03/05/2024$3.16$3.17+0.32%$3.29$3.09421,155 shs$61.02 million03/04/2024$3.68$3.16-14.13%$3.76$3.031.35 million shs$60.83 million03/01/2024$3.71$3.68-0.81%$3.85$3.54601,869 shs$70.84 million02/29/2024$3.75$3.71-1.07%$3.86$3.61320,072 shs$71.42 million02/28/2024$3.94$3.75-4.82%$3.92$3.71297,233 shs$72.19 million02/27/2024$3.96$3.94-0.51%$4.04$3.91365,912 shs$75.85 million02/26/2024$3.90$3.96+1.54%$4.07$3.87314,451 shs$76.23 million02/23/2024$3.80$3.90+2.63%$3.93$3.68386,728 shs$75.08 million02/22/2024$3.65$3.80+4.11%$3.82$3.57332,906 shs$73.14 million02/21/2024$3.70$3.65-1.35%$3.85$3.61465,885 shs$70.26 million02/20/2024$3.78$3.70-2.12%$3.78$3.63446,429 shs$71.23 million02/19/2024$3.78$3.78$4.02$3.71838,700 shs$72.77 million02/16/2024$3.98$3.78-5.03%$4.02$3.71831,520 shs$72.77 million02/15/2024$4.11$3.98-3.16%$4.18$3.95558,933 shs$76.62 million02/14/2024$4.06$4.11+1.23%$4.14$3.96445,537 shs$79.12 million02/13/2024$4.32$4.06-6.02%$4.20$3.95663,607 shs$78.16 million02/12/2024$4.18$4.32+3.35%$4.39$4.15531,262 shs$83.16 million02/09/2024$4.16$4.18+0.60%$4.26$4.08550,305 shs$80.47 million02/08/2024$4.19$4.16-0.84%$4.47$4.131.26 million shs$79.98 million02/07/2024$4.13$4.19+1.45%$4.23$4.08406,098 shs$80.65 million Related Companies: LFVN Stock Price Chart AFMD Stock Price Chart HOOK Stock Price Chart LPTX Stock Price Chart JAGX Stock Price Chart CRVS Stock Price Chart RVPH Stock Price Chart ANEB Stock Price Chart CNTB Stock Price Chart SLS Stock Price Chart Receive TPST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TPST) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.